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How did the study come about?
From the mid-1990s, the success of antiretroviral pro-
phylaxis to reduce HIV RNA viral load in plasma
and avoidance of breastfeeding provided the real
possibility that mother-to-child transmission (MTCT)
of HIV-1 could be markedly reduced,
1 with an
implicit understanding that these measures could
be effectively applied to all HIV-infected women
in developing countries.
2,3 The latter constitute the
overwhelming majority of HIV-positive pregnancies
resulting in approximately half a million new infant
infections annually.
4 However, the inappropriate use
of formula milks amongst impoverished populations
resulted in major adverse effects; without the nutri-
tional and immunological benefits of breastfeeding,
growth failure, malnutrition, diarrhoea and infant
death are common.
5–7
Since 1996, a group at the Nelson Mandela School
of Medicine, University of KwaZulu-Natal (UKZN),
had been pursuing the idea of finding interventions
to reduce breastfeeding transmission of HIV-1 that
would be suitable and safe for populations living in
resource-poor settings. The aim was to find effica-
cious, ethical, acceptable, feasible and sustainable
approaches to prevent post-natal transmission,
while preserving the critical practice of breastfeeding.
The presentation of preliminary evidence in 1999 from
the UKZN group that exclusive breastfeeding (EBF)
might be associated with lower HIV transmission
than mixed breastfeeding (MBF) suggested that
such an aim would be possible,
8 although consider-
able international scientific opposition to attempts to
promote breastfeeding in an high HIV prevalence set-
ting remained.
9 Subsequently, with support from the
Wellcome Trust, UK, the availability of a population-
based site at the Africa Centre for Health and
Population Studies (www.africacentre.ac.za), and
confluence of interests among a small number of indi-
viduals, the conditions were created for the Vertical
Transmission Study (VTS), a non-randomized cohort
intervention study, described here. (‘Mamanengane’
is the Zulu name for the study and means ‘Mother
and Child.’)
Ethical approval was granted by the Biomedical
Research Ethics Committee of UKZN, pilot work
began in 1999 and clinical follow-up of the study
was completed in September 2006.
Study objectives
The primary objectives were to determine the effect of
infant feeding practices on HIV infection rates of
infants at 6 and 22 weeks of age, and the infant
survival rate at 24 months of age according to feeding
practices and HIV status.
The secondary objectives were: to determine the HIV
infection rate of infants as measured on a sample
collected within 72h of birth; the HIV transmission
incidence attributable to the duration of different
feeding practices; the cumulative incidence of MTCT
in EBF, MBF and exclusively formula-fed (EFF)
infants; to describe risk factors, other than feeding
practice, for post-natal transmission of HIV, including
maternal and infant morbidity and breast health; to
assess the determinants of transmission in MBF
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351adjusting for exposure factors e.g. type and age of
introduction of other food/milk; to describe the mor-
bidity and growth of infants in relation to feeding
practices and HIV status; and to describe adherence
rates to EBF following a breastfeeding support
intervention.
What does the study cover?
The study documents the feeding practices, HIV
status, morbidity, mortality, growth and development
of children born to HIV-infected and -uninfected
women from birth to 2 years of age; and morbidity,
mortality, breastfeeding difficulties and breast health
problems of HIV-infected and -uninfected mothers
from the antenatal period to 2 years post-partum.
Where is the study area?
The study had two field sites. The first, and largest,
was in the rural Umkhanyakude district of northern
KwaZulu Natal, where enrolment commenced in
August 2001at eight clinics—one peri-urban and
seven rural (Figure 1). In order to increase the rate of
recruitment, enrolment began at an additional site on
the outskirts of Durban in August 2003 (Figure 1). This
site was urban and the population extremely mobile,
with people migrating at short notice into and out of
the area during pregnancy and post-delivery.
The Africa Centre for Health and Population Studies
(www.africacentre.ac.za) conducts a Africa Centre
Demographic Information System (ACDIS), and
individual HIV surveillance, in a sub-district of
the Umkhanyakude district;
10–13 five of the VTS
recruitment clinics are located within the
Demographic Surveillance Area.
Who is in the sample?
A total of 3445 women were enrolled during preg-
nancy: 2704 women from the eight clinics in
Umkhanyakude and 741 women from the one clinic
outside Durban. Eligibility criteria were: aged 16 years
of age or older, planning to stay in the study area
for at least 3 months after delivery, and provided
written consent.
HIV-uninfected women were included to establish
the effect of HIV status on adherence to EBF, and
to avoid stigmatization of HIV-infected women in
the community, as frequent home visits were part of
the study protocol.
Initially, all HIV-infected women, and a systematic
subsample of uninfected women, were offered enrol-
ment in the study; 1 in 10 women who tested HIV
negative were randomly and confidentially identified
through a computer-based programme from batches
of test results identified only with an encrypted study
number. These women were offered enrolment when
they were subsequently counselled after testing. From
July 2003, all women attending antenatal clinics were
offered enrolment before HIV testing. Although this
resulted in a much larger cohort of HIV-negative
women than originally planned, this negative compar-
ison group is one of the strengths of the study, and
has enabled us to conduct interesting analyses: for
example, comparison of morbidity and growth between
children of HIV-positive and -negative mothers, and
comparisons of maternal morbidity and mortality
between HIV-positive and -negative women. No other
Figure 1 Rural and urban study sites in South Africa
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such a large comparative HIV-uninfected cohort with
detailed data.
Figure 2 shows the number of women eligible for
enrolment and numbers lost to follow-up at different
time periods. Compared with women enrolling, those
refusing to participate in the study were significantly
more likely to live in the peri-urban area and to be
HIV infected (Table 1).
Compared with women who remained active in the
study, those who moved from the study area, with-
drew consent or were lost to follow-up antenatally
were significantly more likely to reside in the urban
site at Durban and to have piped water in their home-
steads; post-natally they were also significantly more
likely to live in the urban site, to be HIV positive and
to have less than four previous pregnancies. There
were no significant differences in terms of educational
attainment or maternal income. Mobility of women
in the urban setting was high, with many women
coming to the area to join partners and to access
antenatal care, but moving away to join their own
families for delivery.
How often have they been
followed up?
Follow-up took place both at clinics and women’s
homes, with the same frequency for HIV-infected
Women eligible for 
enrolment         
N = 4164 
Women who refused to enroll  
) % 7 1 ( 9 1 7 = N
Women who agreed to 
enroll        
N = 3445 (83%) 
Women who were lost to the study prior 
to delivery    (N = 579):               
4 died antenatally 
69 women did not fulfill study criteria after 
enrolment (e.g. were not actually 
pregnant, outside study area) 
18 spontaneous abortions 
283 lost to follow-up 
103 moved out of study area 
102 withdrew consent 
Children delivered, 
including 63 sets of twins   
N = 2938       
Children who were lost to the study 
between birth and 6 months of age 
(N=685):     
106 stillbirths 
161 infant deaths 
102 lost to follow-up 
114 moved out of study area 
t n e s n o c w e r d h t i w 2 0 2
Children who completed 6 
months of follow-up   
N = 2253 
Children who were lost to the study 
between 6 and 24 months of age 
(N=1105):  
96 child deaths 
106 lost to follow-up 
170 moved out of study area 
48 withdrew consent 
Children who completed 
24 months of follow-up   
N = 1833       
Figure 2 Flow diagram of women eligible for enrolment and numbers lost to follow-up during the study
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staff (numbering 140 persons at peak) was required
to conduct this rigorous follow-up over a wide
geographical area. Most study staff were local Zulu
women, with no tertiary education, who were speci-
fically trained for the study (Table 2).
All pregnant women were tested for HIV and coun-
selled at the antenatal clinic, by lay HIV counsellors,
on infant feeding options according to the WHO/
UNAIDS recommendations available at the time.
14,15
HIV-uninfected women were counselled to exclusively
breastfeed for the first 6 months of life with sustained
breastfeeding to at least 2 years. The option of re-
placement feeding (commercial formula feeds) or
EBF for the first 6 months of life was discussed
with HIV-infected women who made decisions
based on their home circumstances. At 5 months,
HIV-infected breastfeeding women were counselled
to stop breastfeeding (at 6 months) of infants who
were confirmed not to be HIV-infected; mothers
were counselled to continue breastfeeding infants
who were already HIV-infected.
16 Women were
Table 1 Characteristics of eligible women who enrolled in the study and those who declined to
participate
Variable
Women who
enrolled
N¼3445
Women who
declined enrolment
N¼719
P-value for difference
between groups
of women
Residence
Rural 1586 (46%) 257 (35.8%) <0.001
Semi-urban 1119 (32.5%) 462 (64.2%)
Urban 740 (21.5%) 0
Maternal HIV status
Positive 1769 (51.4%) 452 (63.4%) <0.001
Negative 1662 (48.3%) 259 (36.3%)
Indeterminate 12 (0.3%) 2 (0.3%)
Highest level of education attained
None 224 (6.5%) 55 (7.7%) 0.479
Primary 1196 (34.7%) 253 (35.2%)
Secondary 2025 (58.8%) 411 (57.1%)
Number of previous pregnancies
0 1228 (35.6%) 240 (33.4%) 0.3
1–4 1981 (57.5%) 434 (60.3%)
4–11 211 (6.1%) 43 (6%)
Missing 25 (0.8%) 2 (0.3%)
Table 2 Training provided to study staff
Staff group Training provided
Clinic assistants 40-h WHO breastfeeding counselling course
14
Training in anthropometry
HIV counsellors 40-h HIV counselling course (local course)
40-h WHO breastfeeding counselling course
14
15-h WHO HIV and infant feeding counselling course
24
Breastfeeding counsellors 40-h WHO breastfeeding counselling course
14
Field monitors IMCI training on respiratory and diarrhoeal disease
Study nurses 40-h WHO breastfeeding counselling course
14
15-h WHO HIV and infant feeding counselling course
24
24-h WHO Complementary feeding counselling course
38
Training in anthropometry
All staff received basic training in numeracy, HIV education, research methods, study protocol, family planning,
sexually transmitted infections, life skills, growth charts, recognition of a sick child.
354 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYencouraged to cease breastfeeding as rapidly as possi-
ble; relatively large numbers (470%) of HIV-infected
women continued to breastfeed beyond 6 months,
despite counselling and access to replacement feeds.
17
Single-dose nevirapine was provided for all HIV-
infected women and their infants any time after
first booking or 28 weeks gestation.
18 Six months
supply of commercial infant formula was offered
free through the KwaZulu Natal PMTCT programme
from the end of 2002, and HIV-infected mothers
could choose to access this supply any time in the
first 12 months of the infants’ life.
18 For those
initiating formula milk from birth, an initial supply
was provided antenatally. At the time of the study,
highly active antiretroviral treatment was not avail-
able through the provincial health services.
Thereafter women were followed up by three sepa-
rate study teams:
  field monitoring (by field monitors)
  breastfeeding counselling (by breastfeeding
counsellors)
  clinic follow-up (by nurses, clinic assistants and
HIV counsellors)
In the rural site the field monitoring and breastfeed-
ing counselling visits were conducted at women’s
homes. In the urban site, owing to concerns about
staff security, separate counselling and monitoring
visits were carried out at the clinic, with the same
frequency as home visits in the rural area.
Breastfeeding counselling
Breastfeeding counsellors visited all enrolled women
at home, antenatally, to discuss study logistics,
explain again the study protocol and ensure women
wanted to participate. Any woman who chose to rep-
lacement feed was referred to the study infant feeding
specialist for support; those choosing to breastfeed
received up to three further antenatal home visits to
discuss breastfeeding issues.
Within 72h of delivery, all women received one
home visit from the breastfeeding counsellor, irrespec-
tive of antenatal feeding intention. Mothers initiating
breastfeeding received a further three home visits in
the first 2 weeks, and fortnightly thereafter, until the
infant was 6 months old. The counsellors supported
women to exclusively breastfeed, and also recorded
information on breast health and breastfeeding
technique (positioning and attachment), but no data
on infant feeding practices, to avoid potential record-
ing bias. Support for formula-feeding mothers was
provided by study nurses at the clinics, and home
visits as required.
Field monitoring
Infant feeding practices were reported to independent
field monitors who visited every week and documen-
ted all feeds (milks and solids), fluids, drugs, morbid-
ity episodes, hospitalization and attendances at health
facilities for every day of the preceding week. Mothers
kept food-intake and morbidity diaries for use during
the field-monitor interview to corroborate the verbal
report. If a mother or main care giver was not present
for a counselling or monitoring visit, the study team
returned on up to 2 consecutive days. Thereafter, the
visit was considered to be a missed visit. Mothers kept
food-intake and morbidity diaries for use during the
field visit to corroborate the verbal report.
Neither feeding counsellors nor field monitors
were aware of the mothers’ HIV status. Home visits
by the breastfeeding counsellors (for women who
were breastfeeding) ceased at 6 months; and monitor-
ing visits by the field monitors (for all women—
breastfeeding or replacement feeding), at 9 months,
post-delivery.
Clinic follow-up
Study staff (study nurse, clinic assistant), based at
health facilities, aimed to see infants as soon as pos-
sible after delivery to record birth data and obtain a
dried blood spot.
Further clinic visits were scheduled to coincide with
routine infant immunizations to avoid unnecessary
visits—at 6, 10, 14, 18, 22, 26 weeks and then 7, 8,
9, 12, 15, 18, 21, 24 months after delivery. If infants
did not attend at around 6 and 26 weeks post-deliv-
ery, attempts were made to trace the women, and if
necessary, to bring them and their infant to the clinic
for assessment.
At every visit, the study nurse documented a med-
ical history, examined and conducted anthropometry
on mother and infant and obtained biological speci-
mens. At each visit, a dried blood spot sample was
obtained by heel prick from the infant. HIV status
was established by quantitative HIV RNA assay with
a sensitivity of 80 copies of HIV RNA per millilitre of
blood (equivalent to 1600 copies HIV RNA per 50ml
dried blood spot). A breastmilk sample from each
breast was obtained from breastfeeding mothers.
Venous blood samples were collected at 6 months
from mothers and infants.
What has been measured?
Examples of data collected are shown in Table 3.
There was relatively little missing data for the key
variables, specifically daily feeding practices in the
first 6 months. For the main transmission analyses,
infants were excluded if there were 45 days of miss-
ing feeding data in any 30-day period.
19
Feeding data were collected in line with recom-
mended practices, and after discussion with investi-
gators involved in feeding trials at other sites,
including Zimbabwe,
20 Zambia
21 and Cote d’Ivoire.
22
Strict World Health Organization definitions of feed-
ing were used.
23,24 This similarity in data collection
methods has allowed not only comparisons of our
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Variables Comments where applicable
Socio-demographic factors
Maternal age at delivery
Maternal education Collected in the antenatal period.
Maternal employment Collected in the antenatal period.
Type of water supply, ownership of fridge,
cooking fuel
Collected in the antenatal period.
Pregnancy and birth details
Parity and gravidity Collected at antenatal clinic.
Date of last menstrual period Collected at antenatal clinic.
Gestation at booking visit Collected at antenatal clinic.
Previous infant feeding practices Collected at antenatal clinic.
Gestational age at birth Collected from the delivery facility and delivery maternity records.
Mode of delivery Collected from the delivery facility and delivery maternity records.
Duration of labour Collected from the delivery facility and delivery maternity records.
Duration of rupture of membranes Collected from the delivery facility and delivery maternity records.
Apgar scores Collected from the delivery facility and delivery maternity records.
Birth weight, length, head circumference Weight: from the delivery maternity records; and also measured
by study staff if not too long after delivery.
Length and head circumference from maternity records.
Infant feeding practices
Daily feeding practices Daily information documented at weekly intervals at home.
All foods and fluids given to infant recorded for each day of the
preceding week. Approximate volumes of other food and fluids
given in previous 24h documented.
Maternal breast health problems Daily information documented at 2-weekly intervals at home.
All breast health pathology, per breast, recorded for each day of
the preceding week.
Breastfeeding difficulties Information on breastfeeding difficulties documented since last
visit at 2-weekly intervals at home.
Infant morbidity
Diarrhoea Daily information documented at weekly intervals at home, and at
scheduled clinic visits.
a
Respiratory illness Daily information documented at weekly intervals at home, and at
scheduled clinic visits.
Hospitalizations Daily information documented at weekly intervals at home, and at
scheduled clinic visits.
Other morbidity Daily information documented at weekly intervals at home, and
at scheduled clinic visits.
Drugs given (prescribed) Daily information documented at weekly intervals at home, and
at scheduled clinic visits.
Drugs given (non-prescribed) Daily information documented at weekly intervals at home, and at
scheduled clinic visits.
Clinical diagnosis At scheduled clinic visits by study nurse.
Treatment given (if any) At scheduled clinic visits by study nurse.
Infant growth and development
Weight, length and head circumference Measured on standardized equipment at each scheduled clinic
visit.
a
Development Modified Denver Developmental assessment conducted at each
scheduled clinic visit, including gross motor, fine motor/vision,
social, language/hearing
(continued)
356 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYdata with other studies, but also a pooled analysis of
the VTS data with the West African cohort.
25
All data were documented on study forms that were
optically scanned (Teleform, Cardiff, San Diego, CA,
USA), rather than being manually entered, which
reduced human error in data entry.
Data were stored in a Microsoft SQL Server database
with custom written applications.
What has been found?
Pregnancy outcomes
Compared with HIV-uninfected women, infected
women are at a significantly increased risk of adverse
pregnancy outcomes; adverse pregnancy outcome
was independently associated with HIV infection,
urban enrolment and non-hospital delivery, and
with a CD4 count <200 cells/ml among HIV-infected
women.
26
Infant feeding practices
After infant feeding counselling, the majority of HIV-
infected women chose to breastfeed, and 480%
initiated EBF from birth. Most HIV-infected women
did not have the resources for safe replacement
feeding and chose appropriately to exclusively
breastfeed.
27–30 EBF rates were high in both HIV-
infected and -uninfected women, and counselling
visits were strongly associated with adherence to
cumulative EBF: the median duration of EBF was
177 and 175 days in HIV-negative and -positive
women, respectively. Breast health problems were
rare in all women. The cost of rolling out the breast-
feeding intervention to the province of KwaZulu-
Natal, South Africa, has been calculated.
Post-natal HIV transmission
With regard to post-natal HIV transmission, Kaplan-
Meier estimated risk of acquisition of infection
between 4–6 weeks and 6 months of age was 4%.
31
Breastfed infants who also received solids were
11 times more likely to acquire infection than were
EBF children; infants who at 12 weeks received both
breastmilk and formula milk were twice as likely to
be infected. The few HIV-infected women who experi-
enced any serious breast health problem were
approximately 3 times more likely to transmit HIV
post-natally to their infant.
All publications can be found on the Africa Centre
website: www.africacentre.ac.za. The main study
results have been disseminated widely, and contribu-
ted to revisions in the World Health Organization
guidelines on HIV and infant feeding made after a
Table 3 Continued
Variables Comments where applicable
Maternal health
Weight and mid-upper arm circumference Measured on standardized equipment at each scheduled clinic
visit.
a
Morbidity Intervening morbidity documented at scheduled clinic visits.
Hospitalizations Any hospitalizations documented at scheduled clinic visits.
Clinical diagnosis If unwell, diagnosis recorded by nurse at scheduled clinic visits.
Contraception Contraception used since last visit and at last sex documented
at scheduled clinic visit.
Laboratory markers
Maternal HIV antibody Antenatal at booking visit, ELISA.
Maternal CD4 count Antenatal and 6 months post-natal (September 2001–March 2003;
FACScan, Becton Dickinson and Co., NJ, USA; thereafter Epics
XL, Beckman Coulter, CA, USA).
Maternal viral load 6 months post-delivery.
Infant HIV status Dried blood spot taken at each scheduled clinic visit. Quantitative
HIV RNA assay (Nuclisens HIV-1 QT, Organon Teknika, Boxtel,
the Netherlands, and Nuclisens EasyQ HIV-1, Biomerieux, Boxtel,
the Netherlands) with a sensitivity of 80 copies of HIV RNA per
millilitre of blood (equivalent to 1600 copies HIV RNA per 50ml
dried blood spot.
39
Infant CD4 count 6 months of age.
Infant haemoglobin Taken if clinically indicated.
Breastmilk samples Sample from right and left breast taken from breastfeeding
women at each scheduled clinic visit.
aScheduled clinic visits: weeks 6, 10, 14, 18, 22, 26; then months 7, 8, 9, 12, 15, 18, 21, 24.
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32 EBF for 6 months is
now recommended for HIV-infected mothers unless
formula feeds can be provided in a safe, sustainable
and feasible manner.
Further analyses are in progress to examine infant
growth, morbidity and development and maternal
morbidity related to different feeding modalities and
HIV status. There is increasing evidence that HIV
exposed, but uninfected children, are at higher risk
of morbidity, poor growth and development, com-
pared with unexposed children, but there are few
cohorts with such detailed data on daily feeding and
morbidity patterns, and with a large control group of
children born to HIV-uninfected women, which can
explore these issues.
We have also been granted ethics permission to link
the children from the VTS to the Demographic
Surveillance System (DSS). Whilst the VTS data pro-
vides a rich set of antenatal and early life data, it has
limited data on household composition, household
income, migration, family deaths, other household
shocks and subsequent pregnancies in the study
mother, all factors which impact on child growth
and development between 6 and 24 months of age.
The latter are all collected routinely by the DSS and
there have been three rounds of data collection during
the period of 2-year follow-up for each enrolled VTS
mother. Linkage will facilitate novel analyses on the
impact of family support, household structure and
location on child growth and development and life
course studies of the role of early life antecedents in
outcomes in later childhood and adulthood.
What are the main strengths and
weaknesses of the study?
The study design was intensely debated—whether it
should be a randomized trial or cohort study. After
considered thought, and taking into account opinions
of experts, we decided it would be unethical in this
setting to randomize HIV-infected women to EBF or
EFF. First, feeding practice is a personal choice, and a
woman’s right. A woman is more likely to success-
fully adhere to a feeding option if she feels committed
and convinced about her chosen option. We followed
WHO/UNAIDS guidelines on infant feeding counsel-
ling for HIV-positive women, helping women to make
appropriate choices according to their situations.
24
Secondly, given the socio-demographic profile of the
community, randomizing women to formula feeding
would likely have resulted in significant morbidity
and mortality risks.
6,7,33,34 Thirdly, the post-natal
HIV transmission risk in EFF infants is known to be
zero. We could, therefore, compare any transmission
found in EBF infants, or MBF, against zero.
A cohort study provides a realistic life setting
for infant feeding in the context of HIV. We showed
that high rates of EBF were possible amongst women
choosing this option.
28 Women who chose to formula
feed in general made this choice appropriately. To our
knowledge, there has only been one previous rando-
mized study, from Kenya, examining infant feeding
and HIV transmission. In that study, there was 70%
compliance to feeding mode in the formula feeding
arm, with 30% of the women practising mixed feed-
ing, with more loss to follow-up in the formula feed-
ing than the breastfeeding arm.
35
Strengths
Previous studies were not designed to examine HIV
transmission by feeding mode; the primary aim of
this study was to determine the effect of infant feed-
ing practices on HIV infection rates of infants at 6 and
22 weeks of age. A further important strength of this
study is the large sample size of both HIV-infected
and -uninfected women, and the high proportion of
women who succeeded to exclusively breastfeed.
There were concerns at the start of the study, based
on results of pilot work,
36 that it would be extremely
difficult to support women to exclusively breastfeed in
a society where mixed feeding was the norm from
soon after birth.
Data on infant feeding were meticulously collected.
Previous studies had relied on cross-sectional surveys
of infant feeding, at various time points (e.g. when
the child was 3 and 6 months of age). In these sur-
veys, mothers were asked what foods and drinks they
have given to their child over the past 24 hours
(‘24 hour recall’) or what they have given since
birth until the present time. Both methods have
problems, and are likely to misclassify cumulative
feeding practices.
37 The WHO has well-defined defini-
tions of infant feeding,
23,24 which were used in the
study, and enabled comparisons with other studies.
Furthermore, we used a separate group of field work-
ers to collect the detailed feeding data (field moni-
tors) from those who supported breastfeeding
(breastfeeding counsellors), to minimize bias in
mothers’ reported practices.
Infants were tested for HIV at monthly intervals,
allowing timing of HIV infection, in those infants
who did sero-convert, to within a month in the first
9 months of life.
Weaknesses
As this study was designed to examine the effect of
EBF on post-natal transmission of HIV, we went to
extraordinary lengths to promote and support EBF for
women choosing this feeding option. At the start of
the study, we knew from previous pilot work that
EBF was rare in this population, and that MBF was
the norm in our area.
36 Promotion of EBF was so
successful that there were few women who mixed
fed, and this group was too small for multivariate
358 INTERNATIONAL JOURNAL OF EPIDEMIOLOGYregression analyses, or to address some of the original
objectives (e.g. the cumulative incidence of MTCT in
MBF infants or the determinants of transmission in
MBF infants adjusting for exposure factors, e.g. type
and age of introduction of other food/milk—see Study
Objectives section). In retrospect, we could have ran-
domized the support given to breastfeeding women,
with some receiving half the number of home visits
by the breastfeeding counsellors as others. We could
have then modelled more accurately the effect of the
number of visits on adherence to breastfeeding, and
provided helpful guidance to programme and policy
makers.
In hindsight, it would have been interesting and
useful to have collected information on the partner-
ship arrangements of the women, and whether they
were married, had a current partner or were resident
with the father of the child; and also whether the
women had disclosed their HIV status to anyone,
and if so, to whom. This would have enabled explor-
ing what support there is available within the home
and it would have been interesting to examine adher-
ence to EBF in relation to disclosure of HIV, and
presence in the home of the child’s father.
Can I get hold of the data?
Where can I find out more?
The VTS SQL database is well documented (including
definition of variables and the questionnaires used for
data collection). Information can be obtained from
the Africa Centre website (www.africacentre.ac.za).
Requests to use data require the completion of a
data use request form, which is accompanied by an
analysis plan. For further information regarding data
use please contact rbland@africacentre.ac.za
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